{
  "deck": {
    "metadata": {
      "title": "ADC Clinical Insights Deck",
      "version": "1.0",
      "theme_key": "clinical_modern"
    },
    "slides": [
      {
        "slide_type": "composite",
        "title": "ADC Toxicities",
        "body": [
          {
            "content_type": "table",
            "name": "Toxicities Table",
            "table_type": "comparison_row_grouped",
            "theme": "vertical_accent",
            "headers": [
              "",
              "Toxicities considered to be more of a concern compared to other ADCs used for mBC"
            ],
            "rows": [
              [
                "T-DXd",
                "**ILD**: May avoid in patients with preexisting lung conditions or previous pneumonitis, managed with dose reductions\n**Nausea/vomiting**: managed with antiemetic prophylaxis\n**Asthenia**"
              ],
              [
                "Dato-DXd",
                "**Ocular toxicities** (*see next slide for more information on management*)\n**Mucositis/stomatitis**: Managed with oral steroid mouthwash qid but the ability to prevent/treat is directly dependent on patient compliance and motivation\n**Asthenia**: managed with dose reductions"
              ],
              [
                "SG",
                "**Asthenia**: managed with dose reductions\n**Cytopenias, including neutropenia**: managed with growth factors or dose reductions\n**Diarrhea**: managed with antidiarrheal agents"
              ]
            ]
          },
          {
            "content_type": "markdown",
            "content": "The TROPION-Breast01 safety data for Dato-DXd compared to traditional chemotherapy were notably favored.\n\n\nAttendees agreed that Dato-DXd had a lower potential for severe side effects observed with other ADCs, such as ILD and severe diarrhea.\n\n\nThe unique toxicities associated with Dato-DXd may pose initial treatment challenges for physicians due to lack of familiarity; however, these toxicities can be effectively managed with more experience.\n\n\n- According to one attendee, dry eye is generally more manageable than more severe ocular toxicities (eg, keratitis) observed with other cancer therapies\n\n- Effective patient education on ocular toxicities and mucositis requires a multidisciplinary approach involving oncologists, nurses, and pharmacists\n\n- Attendees recommended Dato-DXd starter kits with steroid mouthwash and eye drops or integrated EMR prescribing lists to support side effect prevention and management\n\n\nSG tolerability is a challenge, commonly requiring dose reductions, lower starting doses, or alternate dosing schedules (Days 1 and 15 instead of Days 1 and 8).\n\n\n- Side effects observed with SG align closely with traditional chemotherapy\n\n- One attendee mentioned that oral chemotherapy is better tolerated than SG"
          }
        ]
      },
      {
        "slide_type": "content",
        "title": "Attendee Demographics",
        "body": [
          {
            "component": "chart",
            "chartType": "horizontal_bar_chart",
            "name": "Years Post-Residency Treating Patients With BC",
            "bucket_label": "Years",
            "count_label": "Physicians",
            "aggregations": {
              ">25": 20,
              "21 to 25": 0,
              "16 to 20": 30,
              "11 to 15": 30,
              "7 to 10": 10,
              "4 to 6": 0,
              "0 to 3": 10
            }
          },
          {
            "component": "chart",
            "chartType": "horizontal_bar_chart",
            "name": "Patient Location:",
            "bucket_label": "Physicians",
            "count_label": "Patients",
            "aggregations": {
              ">50": 20,
              "31 to 50": 10,
              "21 to 30": 30,
              "11 to 20": 20,
              "6 to 10": 40,
              "1 to 5": 0
            }
          },
          {
            "component": "chart",
            "chartType": "donut_chart",
            "name": "How comfortable are you managing ocular toxicities?",
            "aggregations": {
              "Treat the patient": 20,
              "Refer to an optometrist": 40,
              "Refer to ophthalmologist": 40
            }
          }
        ]
      },
      {
        "slide_type": "composite",
        "title": "Preferred Treatment by Patient Characteristics",
        "body": [
          {
            "content_type": "table",
            "name": "Preferred Treatment Table",
            "table_type": "comparison_row_grouped",
            "theme": "vertical_accent_2",
            "headers": [
              "",
              "Preferred Treatment by Patient Characteristics"
            ],
            "rows": [
              [
                "T-DXd",
                "- Preferred in most patients unless noted below"
              ],
              [
                "Dato-DXd",
                "- Patients who are not candidates for T-DXd and adherent to steroid mouthwash prophylaxis\n- Patients who prefer the toxicity profile of Dato-DXd over the other ADCs\n- Patients with preexisting lung disease or drug-induced ILD\n- Patients with bone-only metastases or less aggressive disease (QOL impact may be prioritized over response rate)"
              ],
              [
                "SG",
                "- [Before Dato-DXd data were presented] Patients who are not candidates for T-DXd\n- [After Dato-DXd data were presented] Patients who are not candidates for T-DXd and are not adherent to steroid mouthwash prophylaxis"
              ]
            ]
          },
          {
            "content_type": "table",
            "name": "Institution Listing",
            "table_type": "data_listing",
            "theme": "header_accent",
            "headers": [
              "Institution",
              "# of Attendees"
            ],
            "rows": [
              [
                "Advocate Lutheran General Hospital",
                "1"
              ],
              [
                "Beloit Clinic",
                "1"
              ],
              [
                "Highlands Oncology Group | Fayetteville",
                "1"
              ],
              [
                "Illinois Cancer Specialists",
                "1"
              ],
              [
                "Mercy Clinic | Saint Louis",
                "1"
              ],
              [
                "Northwest Cancer Center | Crown Point",
                "1"
              ],
              [
                "Oakland University William Beaumont School of Medicine",
                "1"
              ],
              [
                "Sanford Roger Maris Cancer Center",
                "1"
              ],
              [
                "Texas Oncology | Amarillo",
                "1"
              ]
            ]
          }
        ]
      },
      {
        "slide_type": "composite",
        "title": "Three Tables (Left Full, Right Split)",
        "body": [
          {
            "content_type": "table",
            "name": "Left Full Table",
            "table_type": "comparison_row_grouped",
            "theme": "vertical_accent",
            "headers": [
              "",
              "Left Column Full Table"
            ],
            "rows": [
              [
                "Label A",
                "- Dummy point A1\n- Dummy point A2"
              ],
              [
                "Label B",
                "- Dummy point B1\n- Dummy point B2"
              ],
              [
                "Label C",
                "- Dummy point C1\n- Dummy point C2"
              ]
            ]
          },
          [
            {
              "content_type": "table",
              "name": "Right Top Table",
              "table_type": "data_listing",
              "theme": "header_accent",
              "headers": [
                "Institution",
                "# of Attendees"
              ],
              "rows": [
                [
                  "Dummy Hospital A",
                  "1"
                ],
                [
                  "Dummy Clinic B",
                  "2"
                ],
                [
                  "Dummy Center C",
                  "3"
                ]
              ]
            },
            {
              "content_type": "table",
              "name": "Right Bottom Table",
              "table_type": "comparison_row_grouped",
              "theme": "vertical_accent_2",
              "headers": [
                "",
                "Right Bottom Table"
              ],
              "rows": [
                [
                  "X",
                  "- Dummy X1"
                ],
                [
                  "Y",
                  "- Dummy Y1"
                ],
                [
                  "Z",
                  "- Dummy Z1"
                ]
              ]
            }
          ]
        ]
      },
      {
        "slide_type": "composite",
        "title": "Three Tables (Right Full, Left Split)",
        "body": [
          [
            {
              "content_type": "table",
              "name": "Left Top Table",
              "table_type": "data_listing",
              "theme": "header_accent",
              "headers": [
                "Institution",
                "# of Attendees"
              ],
              "rows": [
                [
                  "Dummy Hospital D",
                  "1"
                ],
                [
                  "Dummy Clinic E",
                  "2"
                ],
                [
                  "Dummy Center F",
                  "3"
                ]
              ]
            },
            {
              "content_type": "table",
              "name": "Left Bottom Table",
              "table_type": "comparison_row_grouped",
              "theme": "vertical_accent",
              "headers": [
                "",
                "Left Bottom Table"
              ],
              "rows": [
                [
                  "P",
                  "- Dummy P1"
                ],
                [
                  "Q",
                  "- Dummy Q1"
                ],
                [
                  "R",
                  "- Dummy R1"
                ]
              ]
            }
          ],
          {
            "content_type": "table",
            "name": "Right Full Table",
            "table_type": "comparison_row_grouped",
            "theme": "vertical_accent_2",
            "headers": [
              "",
              "Right Column Full Table"
            ],
            "rows": [
              [
                "Label D",
                "- Dummy point D1\n- Dummy point D2"
              ],
              [
                "Label E",
                "- Dummy point E1\n- Dummy point E2"
              ],
              [
                "Label F",
                "- Dummy point F1\n- Dummy point F2"
              ]
            ]
          }
        ]
      },
      {
        "slide_type": "composite",
        "title": "Three Tables (Left Full, Right Split)",
        "body": [
          {
            "content_type": "table",
            "name": "Left Full Table",
            "table_type": "comparison_row_grouped",
            "theme": "vertical_accent",
            "headers": [
              "",
              "Left Column Full Table"
            ],
            "rows": [
              [
                "Label A",
                "- Dummy point A1\n- Dummy point A2"
              ],
              [
                "Label B",
                "- Dummy point B1\n- Dummy point B2"
              ],
              [
                "Label C",
                "- Dummy point C1\n- Dummy point C2"
              ]
            ]
          },
          [
            {
              "content_type": "table",
              "name": "Right Top Table",
              "table_type": "data_listing",
              "theme": "header_accent",
              "headers": [
                "Institution",
                "# of Attendees"
              ],
              "rows": [
                [
                  "Dummy Hospital A",
                  "1"
                ],
                [
                  "Dummy Clinic B",
                  "2"
                ],
                [
                  "Dummy Center C",
                  "3"
                ]
              ]
            },
            {
              "content_type": "markdown",
              "content": "The TROPION-Breast01 safety data for Dato-DXd compared to traditional chemotherapy were notably favored.\n\n\nAttendees agreed that Dato-DXd had a lower potential for severe side effects observed with other ADCs, such as ILD and severe diarrhea.\n\n\nThe unique toxicities associated with Dato-DXd may pose initial treatment challenges for physicians due to lack of familiarity; however, these toxicities can be effectively managed with more experience.\n\n\n- According to one attendee, dry eye is generally more manageable than more severe ocular toxicities (eg, keratitis) observed with other cancer therapies"
            }
          ]
        ]
      }
    ]
  }
}
